These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38552415)

  • 1. Factors associated with one-year mortality after curative surgery for primary clinical T4 and locally recurrent rectal cancer in elderly patients.
    van Ham NCM; Glazemakers S; van der Ende-van Loon M; Nieuwenhuijzen GAP; Rutten HJT; Tolenaar JL; Jacobs A; Burger JWA; Ketelaers SHJ; Bloemen JG
    Eur J Surg Oncol; 2024 Jun; 50(6):108259. PubMed ID: 38552415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related differences in morbidity and mortality after surgery for primary clinical T4 and locally recurrent rectal cancer.
    Ketelaers SHJ; Voogt ELK; Simkens GA; Bloemen JG; Nieuwenhuijzen GAP; de Hingh IHJ; Rutten HJT; Burger JWA; Orsini RG
    Colorectal Dis; 2021 May; 23(5):1141-1152. PubMed ID: 33492750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 4. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
    Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
    Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of urinary diversion after surgery for locally advanced or locally recurrent rectal cancer with complete cystectomy; ileal and colon conduit.
    Hagemans JAW; Voogt ELK; Rothbarth J; Nieuwenhuijzen GAP; Kirkels WJ; Boormans JL; Koldewijn EL; Richardson R; Verhoef C; Rutten HJT; Burger JWA
    Eur J Surg Oncol; 2020 Jun; 46(6):1160-1166. PubMed ID: 32122756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of nutritional status and body composition on postoperative outcomes after pelvic exenteration for locally advanced and locally recurrent rectal cancer.
    van Rees JM; Visser E; van Vugt JLA; Rothbarth J; Verhoef C; van Verschuer VMT
    BJS Open; 2021 Sep; 5(5):. PubMed ID: 34672343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
    Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S
    Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
    Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
    BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer.
    Westberg K; Palmer G; Hjern F; Nordenvall C; Johansson H; Holm T; Martling A
    Br J Surg; 2017 Dec; 104(13):1866-1873. PubMed ID: 29023631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
    Detering R; Karthaus EG; Borstlap WAA; Marijnen CAM; van de Velde CJH; Bemelman WA; Beets GL; Tanis PJ; Aalbers AGJ;
    Eur J Surg Oncol; 2019 Nov; 45(11):2059-2069. PubMed ID: 31230980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical outcomes for 187 patients with locally recurrent rectal cancer and analysis of prognostic factors].
    Jiang Y; Wan YL; Liu YC; Wang X; Pan YS; Wu T; Wang PY; Huang SJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):582-5. PubMed ID: 21866446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.
    Gould LE; Pring ET; Moorghen M; Burns EM; Antoniou A; Steele CW; Roxburgh CS; Jenkins JT
    Eur J Surg Oncol; 2023 Nov; 49(11):106971. PubMed ID: 37442715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.
    Westberg K; Palmer G; Hjern F; Holm T; Martling A
    Br J Surg; 2019 May; 106(6):790-798. PubMed ID: 30776087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients.
    Selvaggi F; Fucini C; Pellino G; Sciaudone G; Maretto I; Mondi I; Bartolini N; Caminati F; Pucciarelli S
    Tech Coloproctol; 2015 Mar; 19(3):135-44. PubMed ID: 25384359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
    Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative
    Colorectal Dis; 2024 May; 26(5):926-931. PubMed ID: 38566456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
    Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
    Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration].
    Chen GL; Wang YL; Zhang X; Tao Y; Sun YH; Chen JN; Wang SQ; Su N; Wang ZG; Zhang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):268-276. PubMed ID: 36925127
    [No Abstract]   [Full Text] [Related]  

  • 19. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer: Comparative analysis of two national cross-sectional cohorts.
    van Geffen EGM; Langhout JMA; Hazen SJA; Sluckin TC; van Dieren S; Beets GL; Beets-Tan RGH; Borstlap WAA; Burger JWA; Horsthuis K; Intven MPW; Aalbers AGJ; Havenga K; Marinelli AWKS; Melenhorst J; Nederend J; Peulen HMU; Rutten HJT; Schreurs WH; Tuynman JB; Verhoef C; de Wilt JHW; Marijnen CAM; Tanis PJ; Kusters M; On Behalf Of The Dutch Snapshot Research Group
    Eur J Cancer; 2024 May; 202():114021. PubMed ID: 38520925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.